Company intelligence / Profile preview

VGYAAN Pharmaceuticals

Skillman, New Jersey, United Statesvgyaan.com ↗

Ownership: Private
Employees: ~24
Development stage: Commercial

Overview

VGYAAN Pharmaceuticals develops and commercializes clinically critical therapies with a focus on generic drugs and 505(b)(2) products. The company has several FDA-approved products on the market across psychotropic, oncology, cardiovascular, and gastrointestinal categories. It is now part of RK Pharma Inc., which enhances its manufacturing capabilities and supply chain reliability.

Therapeutic areas: OncologyPsychiatryCardiovascularGastroenterology
Modalities: Small molecules (oral and injectable generics, 505(b)(2) drugs)
Industry: Biotech

Partnerships

Premier Inc. – joint venture to co-develop at-risk generic injectables for U.S. hospitals

Beyond the preview

Go deeper on VGYAAN Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VGYAAN Pharmaceuticals.

Explore the full profile